Cargando…

Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases

The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Soo-Kyung, Choi, Chang Hwan, Chun, Jaeyoung, Lee, Heeyoung, Kim, Eun Sun, Park, Jae Jun, Park, Chan Hyuk, Lee, Bo-In, Jung, Yunho, Park, Dong-Il, Kim, Do Young, Park, Hana, Jeen, Yoon Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000641/
https://www.ncbi.nlm.nih.gov/pubmed/32013312
http://dx.doi.org/10.5217/ir.2019.09155
_version_ 1783494076378644480
author Park, Soo-Kyung
Choi, Chang Hwan
Chun, Jaeyoung
Lee, Heeyoung
Kim, Eun Sun
Park, Jae Jun
Park, Chan Hyuk
Lee, Bo-In
Jung, Yunho
Park, Dong-Il
Kim, Do Young
Park, Hana
Jeen, Yoon Tae
author_facet Park, Soo-Kyung
Choi, Chang Hwan
Chun, Jaeyoung
Lee, Heeyoung
Kim, Eun Sun
Park, Jae Jun
Park, Chan Hyuk
Lee, Bo-In
Jung, Yunho
Park, Dong-Il
Kim, Do Young
Park, Hana
Jeen, Yoon Tae
author_sort Park, Soo-Kyung
collection PubMed
description The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis is determined by the interaction between the virus and the host’s immunity, and the risk of reactivation increases if immunity is compromised by immunosuppression therapy. Parts of Asia, including Korea, still show intermediate endemicity for the hepatitis A virus and hepatitis B virus compared with the United States and Western Europe. Thus, members of IBD research group of the Korean Association for the Study of Intestinal Diseases have produced a guideline on the prevention and management of viral hepatitis in IBD.
format Online
Article
Text
id pubmed-7000641
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Korean Association for the Study of Intestinal Diseases
record_format MEDLINE/PubMed
spelling pubmed-70006412020-02-12 Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases Park, Soo-Kyung Choi, Chang Hwan Chun, Jaeyoung Lee, Heeyoung Kim, Eun Sun Park, Jae Jun Park, Chan Hyuk Lee, Bo-In Jung, Yunho Park, Dong-Il Kim, Do Young Park, Hana Jeen, Yoon Tae Intest Res Review The treatment of inflammatory bowel disease (IBD) has been revolutionized for the last 10 years by the increasing use of immunomodulators and biologics. With immunosuppression of this kind, opportunistic infection is an important safety concern for patients with IBD. In particular, viral hepatitis is determined by the interaction between the virus and the host’s immunity, and the risk of reactivation increases if immunity is compromised by immunosuppression therapy. Parts of Asia, including Korea, still show intermediate endemicity for the hepatitis A virus and hepatitis B virus compared with the United States and Western Europe. Thus, members of IBD research group of the Korean Association for the Study of Intestinal Diseases have produced a guideline on the prevention and management of viral hepatitis in IBD. Korean Association for the Study of Intestinal Diseases 2020-01 2020-01-30 /pmc/articles/PMC7000641/ /pubmed/32013312 http://dx.doi.org/10.5217/ir.2019.09155 Text en © Copyright 2020. Korean Association for the Study of Intestinal Diseases. All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Park, Soo-Kyung
Choi, Chang Hwan
Chun, Jaeyoung
Lee, Heeyoung
Kim, Eun Sun
Park, Jae Jun
Park, Chan Hyuk
Lee, Bo-In
Jung, Yunho
Park, Dong-Il
Kim, Do Young
Park, Hana
Jeen, Yoon Tae
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
title Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
title_full Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
title_fullStr Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
title_full_unstemmed Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
title_short Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases
title_sort prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the korean association for the study of intestinal diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000641/
https://www.ncbi.nlm.nih.gov/pubmed/32013312
http://dx.doi.org/10.5217/ir.2019.09155
work_keys_str_mv AT parksookyung preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT choichanghwan preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT chunjaeyoung preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT leeheeyoung preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT kimeunsun preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT parkjaejun preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT parkchanhyuk preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT leeboin preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT jungyunho preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT parkdongil preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT kimdoyoung preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT parkhana preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT jeenyoontae preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases
AT preventionandmanagementofviralhepatitisininflammatoryboweldiseaseaclinicalpracticeguidelinebythekoreanassociationforthestudyofintestinaldiseases